Researchers at Chiba University in Japan have made a substantial breakthrough in identifying the causative substance of chronic inflammation. This discovery, which can potentially lead to more effective and targeted treatments, came after painstaking research. The details of this scientific achievement will be unveiled in the forthcoming scientific journal to broaden the understanding of chronic illnesses.

In Japan, where healthcare facilities are advanced, there's a profound interest in the population towards any advancement in the medical field. Chronic diseases such as diabetes, heart disease, and lung disease form a significant burden on the country's health resources, hence any discoveries related to chronic illness is of high importance. This news gains wide traction and receives public and private endorsements.

Just like in Japan, the US and EU also heavily prioritize utilizing science and technology in combating diseases, particularly the chronic ones. With a high percentage of chronic disease cases, they too would applaud such news and would most likely investigate collaborations, further research, trials, or implementation.